Physician profile
Steven C Zeiller
NPI 1003817602
$229,026.98
in general payments reported to CMS, 2019-2025
16 companies · $34.52 in 2025
The $34.52 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $864 · 2021: $26K · 2022: $58K · 2023: $72K · 2024: $56K · 2025: $34.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $127K · Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $126,963.10 |
| Food and Beverage | $724.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ulrich Medical USA, INC. | $208,566.75 | 2019-2024 | |
| Life Spine, INC. | $13,661.58 | 2019 | |
| Spinal Elements, INC. | $2,096.89 | 2019-2021 | |
| Alphatec Spine, INC | $1,500.00 | 2019 | |
| Precision Spine, INC. | $1,116.00 | 2021-2022 | |
| Stryker Corporation | $848.50 | 2020-2024 | Triathlon, Gamma, Mako |
| Abbott Laboratories | $394.39 | 2019-2022 | |
| Integrity Implants INC. Dba Accelus | $385.31 | 2023-2024 | |
| Nuvasive, INC. | $106.01 | 2019 | |
| Boston Scientific Corporation | $84.74 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $80.22 | 2019-2021 | |
| Integrity Implants INC. | $61.70 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $39.48 | 2019 | |
| Intrinsic Therapeutics | $38.04 | 2021 | |
| Nevro Corp. | $31.08 | 2019-2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $16.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Zeiller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.